Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 21;22(4):2147.
doi: 10.3390/ijms22042147.

Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS)

Affiliations
Review

Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS)

Fumi Miyagawa et al. Int J Mol Sci. .

Abstract

Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS) is a severe type of adverse drug eruption associated with multiorgan involvement and the reactivation of human herpesvirus 6, which arises after prolonged exposure to certain drugs. Typically, two waves of disease activity occur during the course of DIHS/DRESS; however, some patients experience multiple waves of exacerbation and remission of the disease. Severe complications, some of which are related to cytomegalovirus reactivation, can be fatal. DIHS/DRESS is distinct from other drug reactions, as it involves herpes virus reactivation and can lead to the subsequent development of autoimmune diseases. The association between herpesviruses and DIHS/DRESS is now well established, and DIHS/DRESS is considered to arise as a result of complex interactions between several herpesviruses and comprehensive immune responses, including drug-specific immune responses and antiviral immune responses, each of which may be mediated by distinct types of immune cells. It appears that both CD4 and CD8 T cells are involved in the pathogenesis of DIHS/DRESS but play distinct roles. CD4 T cells mainly initiate drug allergies in response to drug antigens, and then herpesvirus-specific CD8 T cells that target virus-infected cells emerge, resulting in tissue damage. Regulatory T-cell dynamics are also suggested to contribute to the diverse symptoms of DIHS/DRESS. However, the pathomechanisms of this complex disease remain largely unknown. In particular, how viral infections contribute to the pathogenesis of DIHS/DRESS and why autoimmune sequelae arise in DIHS/DRESS are yet to be elucidated. This review describes the clinical features of DIHS/DRESS, including the associated complications and sequelae, and discusses recent advances in our understanding of the immunopathogenic mechanisms of DIHS/DRESS.

Keywords: autoimmune disease; drug reaction with eosinophilia and systemic symptoms; drug-induced hypersensitivity syndrome; herpesvirus; pathomechanism; severe cutaneous adverse reactions.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Scheme depicting the clinical course and immunological mechanism involved in DIHS/DRESS. DIHS/DRESS are considered to occur as a result of complex interactions between several herpesviruses and comprehensive immune responses, including drug-specific immune responses and antiviral immune responses. After the resolution of the disease, autoimmune responses may appear.
Figure 2
Figure 2
Clinical manifestations of DIHS/DRESS. (a) Facial erythema, scaling, and peri-orbital edema. (b) Diffuse erythematous rash on the back. (c) Pustules on the face. (d) Purpura on the legs.

References

    1. Shiohara T., Iijima M., Ikezawa Z., Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br. J. Dermatol. 2007;156:1083–1084. doi: 10.1111/j.1365-2133.2007.07807.x. - DOI - PubMed
    1. Kardaun S., Sidoroff A., Valeyrie-Allanore L., Halevy S., Davidovici B., Mockenhaupt M., Roujeau J. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: Does a DRESS syndrome really exist? Br. J. Dermatol. 2007;156:609–611. doi: 10.1111/j.1365-2133.2006.07704.x. - DOI - PubMed
    1. Bocquet H., Bagot M., Roujeau J.C. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS) Semin. Cutan. Med. Surg. 1996;15:250–257. doi: 10.1016/S1085-5629(96)80038-1. - DOI - PubMed
    1. Shiohara T., Mizukawa Y. Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019. Allergol. Int. 2019;68:301–308. doi: 10.1016/j.alit.2019.03.006. - DOI - PubMed
    1. Chen C.B., Abe R., Pan R.Y., Wang C.W., Hung S.I., Tsai Y.G., Chung W.H. An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity. J. Immunol. Res. 2018;2018:6431694. doi: 10.1155/2018/6431694. - DOI - PMC - PubMed

MeSH terms